Home/BioArctic/Oskar Bosson
OB

Oskar Bosson

VP, Head of IR & Communication

BioArctic

BioArctic Pipeline

DrugIndicationPhase
LecanemabAlzheimer's DiseaseLaunched
BAN2802Parkinson's DiseasePhase 1
BAN2401Alzheimer's DiseasePreclinical
Stem Cell ProgramALSResearch